Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
17.05
-0.14 (-0.81%)
Apr 15, 2025, 4:00 PM EDT - Market closed

Enliven Therapeutics Analyst Ratings

Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$38.20
Upside
+124.05%

Ratings History

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$37$39
Strong Buy Maintains $37$39 +128.74% Mar 21, 2025
BTIG
BTIG
Strong Buy
Initiates
$42
Strong Buy Initiates $42 +146.33% Dec 13, 2024
Baird
Baird
Buy
Maintains
$32$40
Buy Maintains $32$40 +134.60% Nov 15, 2024
Jones Trading
Jones Trading
Strong Buy
Initiates
$36
Strong Buy Initiates $36 +111.14% Oct 31, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$37
Strong Buy Reiterates $37 +117.01% Oct 1, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$37
Strong Buy Initiates $37 +117.01% Sep 9, 2024
Baird
Baird
Buy
Initiates
$32
Buy Initiates $32 +87.68% Jun 11, 2024
Mizuho
Mizuho
Strong Buy
Initiates
$34
Strong Buy Initiates $34 +99.41% Apr 9, 2024
Jefferies
Jefferies
Strong Buy
Initiates
$27
Strong Buy Initiates $27 +58.36% Mar 29, 2023
TD Cowen
TD Cowen
Buy
Initiates
n/a
Buy Initiates n/a n/a Mar 3, 2023